James Cummings
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About James Cummings
The proxy statement of Vaxart, Inc. reports total compensation of $1,212,535 for James Cummings in fiscal 2024, including a base salary of $488,087. Disclosed compensation is on record for 4 fiscal years. James Cummings has spoken on 1 earnings call and 1 other investor event across 1 company, most recently for Vaxart, Inc. on March 13, 2026.
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Vaxart, Inc. (VXRT)
Proxy statement
CurrentStart not stated–present
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at Vaxart, Inc.
Other people whose current roles at this company are on record from its filings.
- Andrei Floroiu CEO
- Michael Finney CEO
- Michael J. Finney CEO, Board Member
- Steven Lo CEO, Board Member
- Fuad Ahmad CFO
- Phillip E. Lee CFO, Chief Accounting Officer
- Edward Berg General Counsel
- Jeroen Grasman Chief Accounting Officer
- David Wheadon Board Member
- David Wheadon, M.D. Board Member
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2024 | Vaxart, Inc. (VXRT) | Chief Medical Officer | $488,087 | $1,212,535 |
| 2023 | Vaxart, Inc. (VXRT) | Chief Medical Officer | $454,667 | $1,174,934 |
| 2022 | Vaxart, Inc. (VXRT) | Chief Medical Officer | $430,000 | $1,934,123 |
| 2021 | Vaxart, Inc. (VXRT) | Chief Medical Officer | $112,154 | $2,379,993 |
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.